Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - OCULAR THERAPEUTIX, INC | ocul-20171231ex3224bb44e.htm |
| EX-32.1 - EX-32.1 - OCULAR THERAPEUTIX, INC | ocul-20171231ex3210a27db.htm |
| EX-31.2 - EX-31.2 - OCULAR THERAPEUTIX, INC | ocul-20171231ex31286879b.htm |
| EX-31.1 - EX-31.1 - OCULAR THERAPEUTIX, INC | ocul-20171231ex31137c660.htm |
| EX-10.31 - EX-10.31 - OCULAR THERAPEUTIX, INC | ocul-20171231ex1031df51f.htm |
| EX-10.30 - EX-10.30 - OCULAR THERAPEUTIX, INC | ocul-20171231ex1030f212f.htm |
| EX-10.29 - EX-10.29 - OCULAR THERAPEUTIX, INC | ocul-20171231ex1029d7c66.htm |
| 10-K - 10-K - OCULAR THERAPEUTIX, INC | ocul-20171231x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-210777) and Form S-8 (Nos. 333-198240, 333-202886, 333-210059 and 333-216622) of Ocular Therapeutix, Inc. of our report dated March 8, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/PricewaterhouseCoopers LLP
Boston, Massachusetts
March 8, 2018